Cotización Ab Science - AB

	Precios en Tiempo Real	Nivel 2
Forex

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

0.782

Postura de Compra

0.781

Postura de Venta

0.79

Volume Operado de la Acción

25,926

0.772 Rango del Día 0.843

0.77 Rango de 52 semanas 4.465

Capitalización de Mercado [m]

40.72M

Precio Anterior

0.801

Precio de Apertura

0.772

Hora

0.782

Última hora de negociación

09:09:03

Volumen financiero

Precio Promedio Ponderado

Volumen promedio (3 m)

36,537

Acciones en circulación

52,071,069

Rendimiento del Dividendo

Ratio Precio/Utilidad

-3.43

Beneficio por acción (BPA)

-0.23

turnover

970k

Beneficio neto

-11.99M

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.ab-science.com

Sede

Paris, Paris, Fra

Fundado

Ab Science is listed in the Pharmaceutical Preparations sector of the Euronext with ticker AB. The last closing price for Ab Science was 0.80 €. Over the last year, Ab Science shares have traded in a share price range of 0.77 € to 4.465 €.

Ab Science currently has 52,071,069 shares in issue. The market capitalisation of Ab Science is 41.71 € million. Ab Science has a price to earnings ratio (PE ratio) of -3.43.

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN...

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS...

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE THIS DECISION FURTHER STRENGTHENS MASITINIB’S...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.008	-1.01265822785	0.79	0.843	0.77	27643	0.80198774	DE
4	-0.236	-23.1827111984	1.018	1.02	0.77	41977	0.86972396	DE
12	-0.203	-20.6091370558	0.985	1.062	0.77	36537	0.94812061	DE
26	-0.318	-28.9090909091	1.1	1.7	0.77	65549	1.14800213	DE
52	-1.918	-71.037037037	2.7	4.465	0.77	99142	2.20301616	DE
156	-11.498	-93.6319218241	12.28	13.34	0.77	95319	4.64511113	DE
260	-4.618	-85.5185185185	5.4	21.75	0.77	144544	8.46133166	DE

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
ALDRVDrone Volt	0.34 € (8,847.37%)	107.31k
TRACTTeract SA	1.30 € (53.30%)	212.39k
ALNEVNeovacs	0.0003 € (50.00%)	38.68M
ALSPWSpineway	0.132 € (24.88%)	4.56M
ALARFAdeunis	0.896 € (20.75%)	17.22k
ATOAtos SE	0.6612 € (-26.30%)	10.18M
ALTAILighton	14.12 € (-21.56%)	97.11k
ALEUPEuroplasma	0.075 € (-21.05%)	2.72M
OSEOSE Immunotherapeutics	7.38 € (-16.42%)	644.87k
ALVGVEOM Group	0.151 € (-16.11%)	12.65k
ALNEVNeovacs	0.0003 € (50.00%)	38.68M
ALCYBCybergun	0.0001 € (0.00%)	35.1M
BCPBanco Comercial Portugues SA	0.4414 € (-1.43%)	23.42M
LATLatecoere	0.0089 € (11.25%)	20.41M
ALHPIHopium SA	0.009 € (1.12%)	12.85M